Therapeutic potential of Nitazoxanide against Newcastle disease virus: A possible modulation of host cytokines

Newcastle disease (ND) is prevalent among the domesticated and the wild birds and is caused by the avian paramyxovirus serotype-I (APMV-I). It is commonly known to affect chicken, pheasant, ostrich, pigeon and waterfowl. Depending on the virulence, the velogenic NDV strains cause severe respiratory...

Full description

Saved in:
Bibliographic Details
Published inCytokine (Philadelphia, Pa.) Vol. 131; p. 155115
Main Authors Antony, Ferrin, Vashi, Yoya, Morla, Sudhir, Vandna, Mohan, Hari, Kumar, Sachin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.07.2020
Subjects
Online AccessGet full text
ISSN1043-4666
1096-0023
1096-0023
DOI10.1016/j.cyto.2020.155115

Cover

More Information
Summary:Newcastle disease (ND) is prevalent among the domesticated and the wild birds and is caused by the avian paramyxovirus serotype-I (APMV-I). It is commonly known to affect chicken, pheasant, ostrich, pigeon and waterfowl. Depending on the virulence, the velogenic NDV strains cause severe respiratory and nervous disorders with a high mortality rate. The live and killed vaccines are available for the prevention of infection in the market, but the drug for the treatment is not available. Nitazoxanide (NTZ), a member of thiazolides, is an antiparasitic drug. In the present study, the effect of NTZ on the NDV replication was explored. The experiments were conducted in chicken fibroblast cells (DF-1), PBMC, embryonated chicken eggs, and two-week old chickens. The inhibition of the NDV was observed upon post-treatment of NTZ at a concentration of ~12.5 μM. Cytokine profiling of the DF-1, PBMC, and chicken embryonic tissue treated with NTZ revealed significant upregulation in all the cytokines studied except for IL-1β in DF-1 cells. It is plausible that NTZ is involved in causing immune-modulatory effects in poultry. NTZ treatment in two weeks old chicken showed significant reduction in NDV replication in trachea, and lungs, respectively, at 72 h post-infection. Encouraging results from the present study warrants repurposing NTZ as a drug for the treatment of viral infection in poultry. It will also pave the way towards understanding of similar effect against other animal pathogens.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed equally to the work.
ISSN:1043-4666
1096-0023
1096-0023
DOI:10.1016/j.cyto.2020.155115